Partnering

We are actively looking to establish strategic partnerships with global or regional pharma partners to further develop AVX001 in actinic keratosis and basal cell carcinoma.

Please contact Jesper Kihl, CEO of Reccura Therapeutics AS.

Jesper Kihl

Chief Executive Officer and Board Member

send e-mail